5vp1: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 5vp1 is ON HOLD | The entry 5vp1 is ON HOLD until Paper Publication | ||
Authors: Hoffman, I. | Authors: Hoffman, I. | ||
Revision as of 14:09, 27 September 2017
Unreleased structure
The entry 5vp1 is ON HOLD until Paper Publication
Authors: Hoffman, I.
Description: Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders
